Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2092-6413

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers ; volume:51 ; number:5 ; day:9 ; month:5 ; year:2019 ; pages:1-10 ; date:5.2019
Experimental & molecular medicine ; 51, Heft 5 (9.5.2019), 1-10, 5.2019

Creator: Lee, Jinny Claire
Kim, Soo Jung
Hong, Seungpyo
Kim, YoungSoo

Contributor: SpringerLink (Online service)

DOI: 10.1038/s12276-019-0250-2

URN: urn:nbn:de:101:1-2019101812133135707269

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lee, Jinny Claire
Kim, Soo Jung
Hong, Seungpyo
Kim, YoungSoo
SpringerLink (Online service)

Other Objects (12)

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease

Related objects

Reset password